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ABSTRACT The oligoadenylate-synthetase (Oas) gene locus provides innate immune resistance to virus infec-
tion. In mouse models, variation in the Oas1b gene influences host susceptibility to flavivirus infection. However,
the impact of Oas variation on overall innate immune programming and global gene expression among tissues
and in different genetic backgrounds has not been defined. We examined how Oas1b acts in spleen and brain
tissue to limit West Nile virus (WNV) susceptibility and disease across a range of genetic backgrounds. The
laboratory founder strains of the mouse Collaborative Cross (CC) (A/J, C57BL/6J, 129S1/SvImJ, NOD/ShiLtJ,
and NZO/HlLtJ) all encode a truncated, defective Oas1b, whereas the three wild-derived inbred founder strains
(CAST/EiJ, PWK/PhJ, and WSB/EiJ) encode a full-length OAS1B protein. We assessed disease profiles and
transcriptional signatures of F1 hybrids derived from these founder strains. F1 hybrids included wild-type Oas1b
(F/F), homozygous null Oas1b (N/N), and heterozygous offspring of both parental combinations (F/N and N/F).
These mice were challenged with WNV, and brain and spleen samples were harvested for global gene expression
analysis. We found that the Oas1b haplotype played a role in WNV susceptibility and disease metrics, but the
presence of a functional Oas1b allele in heterozygous offspring did not absolutely predict protection against
disease. Our results indicate that Oas1b status as wild-type or truncated, and overall Oas1b gene dosage, link
with novel innate immune gene signatures that impact specific biological pathways for the control of flavivirus
infection and immunity through both Oas1b-dependent and independent processes.
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WNVis amosquito transmittedflavivirus that emerged fromAfrica and
is now endemic within Asia, middle Eastern Europe, Australia, and the
Americas (Courtney et al. 2012).WNV is an enveloped virus carrying a
genome of a positive sense, single-stranded RNA of roughly 11,000
nucleotides in length. While only 20% of individuals infected with
WNV develop symptoms (www.cdc.gov/westnile), symptomatic indi-
viduals can develop clinical illness ranging from West Nile fever to
encephalitis or meningitis linked with severe inflammation in the brain
and spinal cord, and leading to death (Graham et al. 2016). WNV is
among a group of emerging flaviviruses including dengue virus, Zika
Virus, and Japanese encephalitis virus that are global health concerns.
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Understanding their molecular pathogenesis is a major step toward a
therapeutic or adjunctive therapy.
During viral infection, the infected cell senses viral replication
products, including viral nucleic acid, as foreign, nonself macromole-
cules through the actions of pathogen recognition receptors (PRRs),
including RIG-I-like receptors (RLRs), Toll-like receptors (TLRs), and
other PRRs (Suthar et al. 2013). In particular, flaviviruses including
WNV are sensed by the RLRs through binding of viral RNA (Loo
and Gale 2008, 2011; Errett et al. 2013). RNA binding induces RLR
activation and interaction with downstream signaling proteins that
activate transcription factors IRF3, IRF7, and NF-kB to drive innate
immune gene expression and the production of type 1 and III inter-
ferons (IFNs). IFN is secreted by the infected cell to signal through the
IFN receptors on both the infected cell and on bystander cells, to drive
the expression of hundreds of IFN-stimulated genes (ISGs) across the
local tissue (Loo and Gale 2011). Innate immune genes and ISGs have
antiviral and immune modulatory activity to limit viral replication and
spread such that their induction and function are essential for the
control of WNV infection and immunity (Daffis et al. 2009; Suthar
et al. 2010; Lazear et al. 2013; Lazear and Diamond 2015).
The Oas genes including Oas1b are ISGs whose expression is in-
duced by IFN inmost cell types (Elkhateeb et al. 2016, Choi et al. 2015).
In humans, the Oas family contains Oas1, Oas2, Oas3, and Oas-like
(OasL) genes.Oas2 andOas3 genes have high human–mouse sequence
similarity with a 1:1 orthogonal copy. The mouse Oas gene cluster is
located on chromosome 5 and includes Oas1, Oas2, Oas3, and OasL
genes. The Oas1 gene has eight orthogonal copies (Oas1a, Oas1b,
Oas1c, Oas1d, Oas1e, Oas1f, Oas1g, and Oas1h) in mouse compared
to one copy (Oas1) in humans on chromosome 12. These eight mouse
Oas1 genes are the result of gene duplications, rearrangements, and
other evolutionary processes [Choi et al. 2015, for more details of such
genome regions in the CC, see Morgan et al. (2017)]. Most members of
the Oas gene family encode 29-59 oligoadenylate (2-5A) enzymatic
activity that catalyzes adenosine into 29-59-linked oligonucleotides re-
ferred to as oligoadenylates or 2-5A (Kristiansen et al. 2011). 2-5A
serves as a ligand to bind and activate ribonuclease L (RNaseL), a latent
endoribonuclease. When activated during viral infection, RNaseL
serves to suppress viral replication by nucleolytic targeting viral and
host RNAs. RNaseL products of RNA degradation can also serve as
activator ligands of the RLRs, thus stimulating and amplifying further
rounds of innate immune signaling (Malathi et al. 2007, Siddiqui
et al. 2012, Drappier et al. 2015). Among the Oas family members,
Oas1b lacks 2-5A activity, revealing that the antiviral function of
Oas1b is unique and independent of RNaseL activation for control-
ling WNV infection (Scherbik et al. 2006; Courtney et al. 2012;
Elbahesh et al. 2011). Oas1b is found truncated in classical inbred
mouse strains due the presence of a stop codon/nonsense mutation
within the mRNA (Elbahesh et al. 2011). When otherwise expressed
as a full-length protein, OAS1b provides functional antiviral activity
against WNV (Elbahesh et al. 2011). Recent studies found that
OAS1b has a C-terminus domain targeting the endoplasmic retic-
ulum with binding partner protein ABCF3 assisting in antiviral
activity (Courtney et al. 2012). The same study showed that full-
length (nontruncated) Oas1b inhibited OAS1a activity and lowered
2-5A levels in a dose-dependent manner in vivo. Polymorphisms in
Oas1b are also thought to impact the overall host immune response
to virus infection, but how Oas1b operates in immune regulation is
not defined (Bigham et al. 2011).
In vivo studies assessingOas1b function duringWNV infection and
immunity have been largely conducted with traditional inbred mouse
strains, thus limiting analyses of the natural genetic variation of Oas1b
found within populations. Genetic variation of immune genes plays an
important role in infection outcome and contributes to host suscepti-
bility and resistance (Ferris et al. 2013). As noted above, most wild
derived inbred mouse strains produce a full-length Oas1b protein,
whereas most if not all inbred mouse strains, including the strain of
the reference genome, C57BL/6J, have a premature stop codon in
Oas1b that links with susceptibility to WNV infection (Elbahesh
et al. 2011; Mashimo et al. 2002, see Figure 6, Supplemental Material,
Figure S1, and Table 1 and Table 2). To capture the genetic diversity of
Oas1b for functional studies of WNV susceptibility, we evaluated its
expression and linkage with WNV infection outcome and innate im-
mune transcriptional signatures in the CC mouse population (Iraqi
et al. 2012).
The CC is a MPP, which was generated to improve systems genetic
research using the mouse as a model organism. The CC resource is
composed of 70 independently bred, octo-parental recombinant in-
bred mouse strains (Srivastava et al. 2017), out of several hundred lines
started (Shorter et al. 2017). Each CC line inherits haplotypes from
three wild-derived (CAST/EiJ, PWK/PhJ, and WSB/EiJ) and five clas-
sical (A/J, C57BL/6J, 129S1/SvImJ, NOD/ShILtJ, and NZO/HiLtJ) in-
bred strains contributing both functional and nonfunctional OAS1b
proteins into this MPP. Here, we use F1 crosses between CC strains,
generated to understand complex and diverse phenotypic responses to
virus infection (Rasmussen et al. 2014; Graham et al. 2016). The CC
mice are an excellent model ofWNV infection because their intron and
exon structures in theOas gene family are conserved (Choi et al. 2015).
However, utilization of F1s allows sequences to differ between alleles at
a locus, causing allelic heterozygosity between the wild-derived and
classical inbred Oas1b sequences in this panel. Within this panel of
F1s, we can generate classes of F1s based on their Oas1b alleles: func-
tional Oas1b alleles from Dam and Sire (F/F), heterozygous RIX lines
where only the Dam has a functional Oas1b allele (F/N), only the Sire
(N/F), or neither parent has functioning Oas1b alleles (N/N). In pre-
vious work, we used the CCmodel to evaluate host responses to WNV
and observed phenotypic variation that recapitulates the diversity in
WNV susceptibility and outcomes observed in human populations
(Graham et al. 2015, Green et al. 2016a, Green et al. 2016b).
In this study, we performed a coupled analysis of in vivo WNV
infection, viral replication, host transcriptomics, and bioinformatics
analyses to expand this genetic screen to identify regulatory loci (Table 1)
and determine underlying transcriptional responses contributing to
infection outcome. We screened 90 different F1 hybrids between CC
strains infected with WNV to identify quantitative trait loci (QTL)
contributing to disease phenotypes (Figure 1). To investigate the host
response across F1s of different Oas1b haplotypes, transcriptomics was
n Table 1 QTL Loci
Innate Immune Activation QTL
Chromosome and Region Phenotype Candidate Genes
Chr 5: 120–123 Mb Weight loss (D12) Oas1b (see Table S1 for a complete list)
The genomic region identified in chromosome 5 where Oas1b was found. The QTL ranged between 2 and 3 Mb and includes Oas1b. QTL, quantitative trait locus;
Chr, chromosome; D12, day 12 postinfection.
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performed on the spleens of WNV-infected mice at 2, 4, 7, and 12 d
postinfection. This transcriptional profiling revealed innate immune
regulatory networks associated with the Oas1b haplotype. Our obser-
vations show that the CC is an important biomedical model for studies
of human disease, and leveraging newly developed genomic resources
in this model can improve our understanding of host responses con-
trolling WNV infection and immunity.
MATERIALS AND METHODS
Mice and infection
F1s were bred at the University of North Carolina at Chapel Hill under
specific-pathogen-free (SPF) conditions. The 6- to 8-wk-old male mice
were transferred to theUniversity ofWashington andhoused directly in
a biosafety level 2 (BSL-2) laboratorywithin an SPFbarrier facility. After
a resting period, age- and sex-matched 8- to 10-wk-old mice were
subcutaneously inoculated in the rear footpad with 100 PFU WNV
TX-2002-HC (WN-TX). Mice were monitored daily for morbidity
(percentage of initial weight loss) and clinical disease scores. Mice were
then housed under BSL-3 conditions throughout the experiments, and
tissues were processed under BSL-3 conditions. All animal experiments
were approved by the University of Washington Institutional Animal
Care and Use Committee. The Office of Laboratory Animal Welfare of
the National Institutes of Health (NIH) has approved the University of
Washington (A3464-01), and this study was carried out in strict
compliance with the Public Health Service (PHS) Policy on Humane
Care and Use of Laboratory Animals.
Virus
WN-TX was propagated using previously described methods (Graham
et al. 2016; Green et al. 2016). Viral stocks were generated using su-
pernatants collected from infected Vero cell lines and stored at 80.
QTL analysis
To identify polymorphic host loci impacting phenotypic differences, we
usedamodifiedapproachof theDOQTLbioconductorpackage (version
1.6) in R. The additive haplotypemodel was used in our analyses and in
previous studies (Gatti et al. 2014). Under this model the regression
equation is defined as:
gi ¼
X
k
xikak
X8
h¼1
dijðhÞbh þ gi þ ei
where Yi indicates the phenotype for animal i, x is the indicator of
covariate (k) for animal (i), and a is the effect of covariate (k). dij(h) is
assigned to allelic dosage of the founder (h) at locus j. bh is a co-
efficient of the genetic effects in each founder. The second Yi adjusts
for kinship and ei for residual error in the animal (i). In order to generate
additive allelic dosage probabilities for each F1, we generated eight-allele
probabilities for each F1 with half of the probability for each allele coming
from the inbred dam RI, and half coming from the sire RI, based on the
MegaMUGA most recent common ancestor (MRCA) probabilities
(http://csbio.unc.edu/CCstatus/index.py?run=FounderProbs) (Srivastava
et al. 2017). The X-chromosome of these F1 males presents a special case,
where the eight-allele probabilities are inherited fully from the dam RI.
QTL genome scans were performed by regression on the day 12 weight
change on genotype probabilities for each of the eight founder strains
using R (see SupplementalMaterial for executable code). A random-effect
term was included in the model to account for kinship among animals.
A LOD score for each marker was calculated from the likelihood ratio
comparing the regression model described above to a regression model
without the founder genotype probabilities. The statistical significance of
LOD scores was determined via a permutation test. A threshold of
p , 0.05 was used to select significant associations.
DOQTL genotype probability files were generated with each animal
having a unique genome probability entry. In this way, even animals
from the same RIX would have individual (albeit identical) genome
probability entries. This approach allowed us to assess both within- as
well as between-strain phenotypic differences.
An adjusted p-value for each marker was not included because a
permutation test was used to determine statistical significance of the
LOD scores. The supplemental code provided contains hard coded
significance thresholds to match the original analysis from the figures.
Since there is some randomness to the permutation test, the threshold
may display slightly different values if repeated.
Identification of Oas1b allele status
We utilized haplotype probability reconstructions [based on a hidden
Markov model, described in Iraqi et al. (2012) and Srivastava et al.
(2017)] for each CC strain to identify which founder strain haplotype
was present at theOas1b locus. Previous work (Graham et al. 2015) had
confirmed that Oas1b alleles from the CAST/Eij, PWK/PhJ, and WSB/
EiJ strains had read-through codons relative to the reference genome
(Keane et al. 2011), and this read-through variant is associated with
protection from WNV infection. F1s were identified as Oas1b N/N if
each parent had an Oas1b haplotype without the read-through variant
(A/J, C57BL/6J, 129s1/SvImJ, NOD/ShILtJ, or NZO/HILtJ); Oas1b F/F
if each parent had an Oas1b haplotype with the read-through variant
(CAST/EiJ, PWK/PhJ, or WSB/EiJ); and Oas1b heterozygous if only
one parent had the read-through variant.
Oas1b sequence reconstruction
We integrated high confidence nonsynonymous SNPs from the Sanger
mouse genomes project (www.sanger.ac.uk) (Iraqi et al. 2012; Oreper
n Table 2 Table of F1s screened for transcriptomics analysis
Cross OASlb Status Phenotype Oaslb Origin Dam Sire
CC017·CC004 F/F Asymptomatic CAST/WSB Functional Functional
CC019·CC004 F/F Asymptomatic CAST/WSB Functional Functional
CC009·CC040 N/N Symptomatic N/A Null Null
CC006·CC007 N/N Symptomatic N/A Null Null
CC055·CC028 N/F Symptomatic PWK Null Functional
CC003·CC062 F/N Asymptomatic CAST/WSB Functional Null
CC030·CC061 F/N Asymptomatic CAST/WSB Functional Null
The F1s used in analysis along with their Oas1b status, and Oas1b founder origin. Gene expression changes were assessed against mock-infected congenic control
mice for each cross. F/F, functional Oas1b alleles from Dam and Sire; N/N, homozygous null Oas1b; N/A, not applicable; N/F, heterozygous RIX lines where only the
Sire has a functional Oas1b allele; F/N, heterozygous RIX lines where only the Dam has a functional Oas1b allele.
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et al. 2017; Srivastava et al. 2017) of the eight CC founder strains with
the annotated Oas1b exon sequence (Figure S1).
Clinical scoring: CC F1s and their disease definitions
The clinical scoring system used to evaluateWNV-infectedmice was as
follows: 0, healthy mouse (baseline); 1, ruffled fur, lethargy, hunched
posture, no paresis, and normal gait; 2, altered gait and limited move-
ment in one hind limb; 3, lack of movement and paresis in one or both
hind limbs; and 4, moribund.
RNA extraction and quantitative PCR (qPCR) of WNV
Spleen and brain tissue were removed from mock- or WNV-infected
mice.Halfof thebrainwashomogenized immediatelyafterharvest in1·
PBS at 5500 RPM for 20 sec using a Precellys 24 machine and then
centrifuged. Brain supernatant was added to TRI reagent (Ambion).
Spleen tissues were stored in RNAlater (Ambion) and later homoge-
nized in TRI reagent (Ambion). Total RNA was extracted using the
Ribopure RNA Purification Kit (Ambion), with the addition of bromo-
chloropropane (Acros Organics). RNA was converted to cDNA using
the iScript Select cDNA Synthesis Kit (Bio-Rad). Using SYBR Green
(Applied Biosystems) RT-PCR, WNV was quantified relative to
GAPDH by probing cDNA with WNV-specific probes. qPCR results
were recorded as fold change over mock-infected mice using the R
statistical programming language (version 3.1). Results were loaded
into Spotfire (http://spotfire.tibco.com, version 7.5.0.86) to produce
box plots. Relative quantification was performed for WNV detection
through qPCR. The forward and reverse primer used were: Primer
WNV 1160F, 59-TCAGCGATC TCT CCA CCA AAG-39 and Primer
WNV 1229R, 59-GGG TCA GCA CGT TTG TCA TTG-39.
Correlation matrix
Phenotypic results (clinical score, weight loss, and qPCR in spleen and
brain) were loaded into R. Phenotypes were averaged by their genetic
background (F1), tissue type, and time point. The Pearson correlation
function (cor) was performed using R’s stats package and scores were
displayed using the ggplot2 bioconductor package. For a complete
listing of package information, data, and commands, please refer to
the data reproducibility document in Github under correlation analysis.
Determining outcome: symptomatic and asymptomatic
To quantify disease outcome, we usedweight loss and clinical scoring to
segregate the F1s into two broad pathogenic phenotype categories:
asymptomatic or symptomatic. Three animals were assessed for each
F1 and outcome was based on at least one mouse out of three meeting
weight loss or clinical score criteria at any timepoint. Symptomatic were
defined as having weight loss . 10% of original preinfection weight,
clinical score. 1, and/or death, whereas asymptomatic was defined as
having weight loss, 10% of original preinfection weight, clinical score
of 0 or 1, and no death.
Affymetrix target preparation and
microarray hybridization
RNA spleen samples were prepared for whole-transcriptome expres-
sion analysis using the WT PLUS Reagent Kit following the man-
ufacturer’s recommended protocol (Affymetrix, Inc.). Next, 100 ng
total RNA was used to prepare the hybridization-ready targets. In-
dividual sense-strand DNA targets were randomized and hybridized
to Mouse Gene 2.1 ST 96-Array Plates (Affymetrix, Inc.) using the
GeneTitan Multi-Channel Instrument for hybridization, staining,
and washing of arrays, as well as for scanning. Quality control
(QC) metrics for hybridization, labeling and sample quality were
generated using the Affymetrix Expression Console (version
1.3.187) software. All samples passed QC criteria.
CC-probe masking
To ensure that all Affymetrix probes were identified across all CC lines,
previously describedmasking techniques were applied based on the CC
founder data (Graham et al. 2016; Rasmussen et al. 2014). To mask out
inconsistent Affymetrix probes, we used the oligomask R package
designed for CC mouse data (Bottomly et al. 2014). Oligomask uses
VCF files and the oligo package to filter probes prior to normalization
and statistical analysis.
Transcriptomic analysis
SampleswerescreenedforQCandoutlierdetectionusing theAffymetrix
expression console using boxplots, as well as multi-dimensional scaling
analysis and interarray correlation plots using the R statistical
Figure 1 Analysis workflow. The analysis steps for
generating innate immune regulatory networks
and pathways influenced by Oas1b. qPCR, quan-
titative polymerase chain reaction; QTL, quantita-
tive trait loci; RIX, recombinant inbred intercross;
WNV, West Nile virus.
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programming language (https://www.r-project.org, version 3.1), Bio-
conductor (version 2.13), and packages oligo (1.32.0), oligomask
(https://github.com/dbottomly/oligoMask), limma (3.28.4), and corre-
sponding dependencies. Background correction, normalization, probe
masking, and probe summarization were performed with RMA (Ro-
bust Multichip Average) within the oligomask package. The sva pack-
age (3.20) in R was used to correct for plate batch effects. Differential
expression (DE) analysis was performed using the limma bioconductor
package (see statistical analysis under supplemental wiki in Github). A
statistical cutoff of . 1.5-fold change over mock with a Benjamini–
Hochberg-adjusted p-value, 0.05 was applied. The union of all DE
genes for at least one time point in at least one F1 was first obtained
and then filtered for immune genes. Immune genes were selected as
genes identified in immune-related canonical pathways from Inge-
nuity pathway analysis (IPA). This list of immune-related genes was
used for the global heatmap (Figure 4). The ABC (ATP binding
cassette) and oxysterol-binding proteins were added to the screen
to observe their correlation with other known Oas1b binding part-
ners (Courtney et al. 2012). The heatmap was created using the
heatmap.2 function in gplots (3.0.1) in R and bioconductor. A data
report containing executable code can be found in Github under
transcriptional analysis. Data were deposited in the GEO repository
(access number GSE91003).
Mock correlation
Due to infection and sample collection scheduling, most mock samples
were collected at either 2 or 12d postinfection per F1. To ensure that this
had no impact on normalized transcriptional activity, probe-masked
expression data were compared in mocks for two separate F1s, CC
(041x012)F1andCC(004x011)F1, atdays12and28postmock-infection
(data not shown). Pearson correlation in R gave scores (0.9688 and
0.9687) that confirmed high correlation in the expression between
mocks of the same F1s at different time points.
Coexpression heatmap
Coexpression was performed only on genes that were determined to be
statistically significant from the differential expression analysis (thresh-
old: log2 fold change$ 0.58 and FDR# 0.05) in at least one compar-
ison and considered immune-related (see transcriptional analysis).
Pearson correlations were run on the union of log2FC using the
WGCNA and heatmap.2 bioconductor packages in R (Loraine et al.
2015; Gentleman et al. 2004; Smyth 2004)
Pathway and regulator analysis
A list of statistically significant, differentially expressed genes (threshold
of significance of a . 1.5-fold change over mock with a Benjamini–
Hochberg-adjusted p-value # 0.05) were uploaded into IPA for core
analysis to identify enrichment of biological pathways. The tools pro-
duce a list of known biological functions with an enrichment score
(2log p-value) determining how significant those genes are to each
function, and an activation z-score that tells the proposed activation
of that pathway (activated or inhibited).
The z-score is based on knowledge of expression changes (and
functions) in the Ingenuity knowledge base (Krämer et al. 2014). After
the core analysis was performed in IPA, it was exported into Spotfire
(version 7.5.0.86). Plots were created conservatively based on the fol-
lowing criteria: each biological pathway needed a2log p-value$ 1.30
(corresponds to p-value # 0.05), two or more genes in each pathway,
and had to produce an activation z-score. For the regulator effects
network, the F/F, CC(019x002)F1 was analyzed for expression changes
at 2 d postinfection and the top scoring network (antiviral response,
63% known regulators) was observed. Network generation was per-
formed within IPA.
Innate immune networks
Genes detected in linear modeling and correlation analyses were loaded
into IPA and networks were selected based on enrichment for immune-
related pathways. The F/F network was based on the top two highest
scoring networks (immunological disease and inflammatory response
withnetwork scores 36 and33). The F/Nnetworkwas basedon immune
and inflammatory functions (network score 35). The N/N network was
built on functions in cell-to-cell signaling (network score 27). Protein–
protein interactions from the Ingenuity knowledge base were used to
connect ABCF3 and ORPL1 with the transcriptional data. This was
done using the network build and connect tools in IPA. Network data
were then exported into cytoscape (version 3.1.1) to make custom
network figures.
Data availability
A complete description of the data and methods can be found on the
manuscript’s Github page (https://github.com/greener98103/oas1b/
wiki) and in the supplemental file titled “Green_Oas1b_data_policy_
documentation.” This file includes information on strains/lines, var-
iant files from Sanger, and marker files [MUGA platform (Morgan
et al. 2015)]. The data document also contains detailed descriptions,
file locations, and links to executable code for QTL, transcriptional,
and correlation analyses. Gene expression data are in GEO with the
accession number GSE91003. The authors state that all data necessary
for confirming the conclusions presented in the article are repre-
sented fully within the article.
RESULTS
A QTL identified in chromosome 5 found in day
12 weight loss
We conducted QTL mapping across our panel of 90 F1s (Table 1), and
identified an approximate 2.5 Mb region spanning from 120–122.5 Mb
on chromosome 5 (here termed the host response toWNV, region 1, or
Hrw1) (Figure 1A). HrW1 impacted day 12weight loss (Figure 2, A and
C). The Hrw1 aggregate peak contained 70 genes and microRNAs
(excluding predicted genes). The genes under this locus include all
the murine Oas genes as well as genes associated with biological path-
ways including actin cytoskeleton signaling, CD28 signaling in T helper
cells, and integrin signaling (Table S1 and Table S2). The QTL peak sits
over Oas1b. Based on previous mouse studies (Suthar et al. 2013;
Mashimo et al. 2002; Ferguson et al. 2008; Kajaste-Rudnitski et al.
2006), Oas1b is a known driver of disease phenotypes. To determine
which of the eight strains in the CC were influencing the loci, we next
looked at the founder effects driving this QTL.
Loci founder effects
As the CC is derived from eight founder strains, QTL can contrast any
combinations of these founder haplotypes. Figure 2B shows the esti-
mated phenotypic effect of each founder strain haplotype at the locus
on day 12 weight. Haplotype effects are determined as the deviation
from the population mean due to one copy of that founder allele at the
locus. In this way, we can see that the wild-derived inbred strains
CAST/EiJ, PWK/PhJ, and WBS/EiJ ameliorate weight loss (higher
value = less weight lost), whereas the five classic inbred strain alleles
show enhanced weight loss (lower effects). These results are consistent
with a previously reported analysis ofOas1b (Courtney et al. 2012) and
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Figure 2 WNV QTL. (A) Genome scan of 90 F1s from day 12 weight loss with a significant QTL peak on chromosome 5. The top row indicates
chromosome number and the y-axis is the LOD score. The LOD is the degree of concordance for a genetic marker for a phenotype (weight loss at
day 12). The solid red line is p-value = 0.05 and the dotted line is p = 0.1. (B) The upper image is the contribution of each founder in the QTL
(founder effects), where the population average is zero and each colored line represents a different founder’s predicted effect of one allelic copy
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the Sangermouse genomes project (Keane et al. 2011), which show that
classical strains have an early stop codon, whereas wild-derived foun-
ders encode a fully functional protein. These different founder contri-
butions yield a range of complex phenotypes seen in the F1s. Previous
CC studies showed that F1s heterozygous for Oas1b did not guarantee
protection (Graham et al. 2016) and there were likely other immune
Figure 2 Continued.
on an individual’s phenotype (weight percentage at day 12). The lower image shows the LOD score in the lower y-axis. The x-axis shows the locus
in megabases at chromosome 5. Each colored line represents a different founder’s predicted effect on phenotype. The positive alleles on the top
show founder lines contributing to greater than the population mean, and the negative values contributing to less than the population mean. (C)
Weight change at day 12 p.i. The y-axis represents weight percentage (gain or loss) across all RIXs. The x-axis shows the F1 identity and the color
indicates Oas1b haplotype. Blue = F/F, orange = F/N, red = N/F, and black =N/N. (D) Total clinical score per F1 at day 12 p.i. Clinical score was
determined as follows: 0, healthy mouse (baseline); 1, ruffled fur, lethargy, hunched posture, no paresis, and normal gait; 2, altered gait and
limited movement in one hind limb; 3, lack of movement and paresis in one or both hind limbs. qPCR of WNV virus in the spleen (E) and brain (F)
at days 4 and 7 p.i. The y-axis shows fold change over mock and the x-axis shows each F1 background and their days p.i. Each color represents
Oas1b haplotype. Blue = F/F, Orange = F/N, Red = N/F, Black = N/N. LOD, log odds ratio; p.i., postinfection; qPCR, quantitative polymerase
chain reaction; QTL, quantitative trait loci; RIX, recombinant inbred intercross; WNV, West Nile virus.
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factors beyond Oas1b drivingWNV infection outcome. To get a global
view of WNV pathogenesis in the CC, we studied disease responses by
haplotype.
Contribution of Oas1b in preventing viral growth
and neuroinvasion
Guided by the observed allele effects, and the presence of the truncated
stop codon in Oas1b, we binned our F1s into four classes: F/F (any F1
containing CAST/EiJ, PWK/PhJ, and/orWSB/EiJ alleles), N/N (any F1
containing A/J, C57BL/6J, 129S1/SvImJ, NOD/ShiLtJ, and/or NZO/
HILtJ), and the two reciprocal heterozygous classes F/N (a maternally
inherited functional allele and a paternally inherited defective allele)
and N/F (a maternally inherited defective allele and a paternally
inherited functional allele). We measured a variety of WNV disease
response phenotypes and assessed their differences between these
classes. F/F and heterozygous F1s displayed similar fluctuations in
weight at day 12 postinfection (Figure 2C) compared to N/N F1s. Of
the heterozygous F1s, N/F showed a slightly higher distribution in
weight at day 12 compared to F/N haplotype mice. Clinical scores
were also evaluated at day 12 (Figure 2D). Clinical score was calcu-
lated by animal’s appearance and physical function characteristics
(ruffled fur, lethargy, hunched posture, and no paresis) and move-
ment (see Materials and Methods). The only mice that developed
overt clinical scores associated with WNV disease were from the
N/N Oas1b F1s.
WNV is a neuroinvasive virus that first replicates in the spleen and
then progresses to the central nervous system in amanner controlled by
the innate immune response (Suthar et al. 2013; Elbahesh et al. 2011).
To assess viral growth and neuroinvasion, we measured the levels of
WNV virus in the spleen and brain using qPCR. An inability to effec-
tively control WNV growth in the periphery (such as the spleen) facil-
itates viral production and neuroinvasion (Suthar et al. 2013; Green
et al. 2016a; Fredericksen 2014). qPCR results showed that F1s without
functioningOas1b alleles displayed an increased viral load in the spleen
at day 4 (Figure 2E). By day 7, this lack of viral control resulted inWNV
neuroinvasion characterized by virus in the brain (Figure 2F). There
were lower levels of virus in heterozygous F1s in both the spleen at day
4 and in the brain by day 7. The accumulation of virus in N/N was
statistically significant in the brain compared to heterozygous F1s
(p-value = 0.0005) across all time points (2, 4, 7, and 12 d postinfec-
tion). Viral accumulation was not statistically significant in the
spleen, but we observed a correlation between viral qPCR and clinical
score in the N/N and heterozygous F1s (see Figure S2 and Github).
Distribution of infection response
From the 90 F1s used for QTL mapping based on weight loss, we
evaluated 83 F1s because they had clinical metrics of susceptibility to
WNV infection. Responses of each line were captured and an outcome
was determined as asymptomatic or symptomatic. For a line to be
considered symptomatic, infected animals had to exhibit a clinical
Figure 3 Disease outcome under Oas1b functionality. The number of F1s summarized by disease outcome. Outcome was determined as
symptomatic (loss of 10% or greater body weight or succumbed to WNV infection) or asymptomatic (fought off infection and never lost 10%
weight). Each group of mice is binned according to theirOas1b status. The heterozygous F1s are shown by their disease outcome and their allelic
founder contribution. F/N(PWK) means the F1 contains at least one PWK allele (Null/PWK or PWK/Null). F/N(WSB/CAST) means the F1 contains at
least one WSB/CAST allele. The colors indicate each’s F1’s outcome (blue = asymptomatic and red = symptomatic). CC, Collaborative Cross;
WNV, West Nile virus.
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score . 1 or a . 10% loss in weight since the time of infection (see
Materials and Methods). We evaluated infection outcome based on
haplotype (Figure 3). Out of the 83 F1s screened, 47 of them (56%)
were symptomatic and did not contain full-length Oas1b alleles. Only
five F1s lines were asymptomatic with F/F alleles (6%), and zero lines
with F/F alleles were symptomatic. Likewise, no F1s with N/N alleles
were determined to be asymptomatic. F/F Oas1b alleles provided com-
plete protection against WNV clinical disease. Of the asymptomatic
heterozygous F1s, (F/N and N/F), 16 were F/N (19%) compared to
14 N/F (17%). We only observed four symptomatic N/F F1s (5%)
compared to one asymptomatic F/N F1 (1%). We also observed a re-
lationship between viral load and disease phenotypes (see Figure S2).
To identify differences between the heterozygous lines, we looked at
allelic contributions among the eight founder strains. There was a subtle
difference in disease outcomeamong the heterozygous lines but thiswas
likely driven by lines containing an Oas1b allele from the WSB/EiJ or
CAST/EiJ founder strains. F1s that contained the Oas1b allele from the
PWK/PhJ founder strain appeared to only providemoderate protection
compared to either theWSB/EiJ or CAST/EiJ alleles (seeMaterials and
Methods). These observations support previous studies implying a ma-
jor role forOas1b in protection against WNV disease in mice, although
this is the first time a comparison has beenmade between heterozygous
F1s and their Oas1b’s founder effects.
To reveal innate immune signatures drivingWNV susceptibility, we
performed a multi-tier bioinformatics analysis (see Figure 1) involving
genome-wide microarray analysis on a set of F1s with different Oas1b
haplotypes (F/F, F/N, N/F, and N/N), focusing on revealing the profile
of immune-related genes in the spleen at days 2, 4, 7, and 12 post-WNV
infection as compared tomock-infected congenic controlmice (Table 2).
We centered our transcriptional profiling assessment on the spleen to
better understand peripheral immune programming and possible link-
age with the control of viral neuroinvasion.
Coregulatory patterns between Oas1b haplotypes
We performed a transcriptional correlation analysis using the union
of statistically significant genes across F1s with different haplotypes
(Figure 4). Since the genetic backgrounds among F1s vary and those
without Oas1b produced a large amount of differentially expressed
genes (especially in later time points due to increased illness), we
focused on statistically significant immune-related genes. Correla-
tion analysis identified three distinct gene clusters. Functional anal-
ysis was performed to summarize the clusters into known biological
functions. Genes within cluster 1 are largely involved in innate
immunity, genes within cluster 2 include those involved in cellular
signaling, and cluster 3 genes include a role in cell maintenance
(Figure 4).
Figure 4 Heatmap of immune disease modules. Coexpression in spleen at days 2, 4, 7, and 12 postinfection. The heatmap represents differential
expression of 450 genes across seven F1s with different Oas1b functionality (F/F, N/N, F/N, and N/N). Expression is shown as log2(FC) WNV
infected relative to mock. Red marks genes that are upregulated, blue for downregulated, and white represents no log2(FC). The y-axis shows
genes that coregulate based on their directionality and magnitude. The x-axis shows the days postinfection, haplotype, and disease outcome
according to the legend. Listed on the right as cluster 1: innate immunity, cluster 2: Cell maintenance, and cluster 3: cell signaling. log2(FC), log2
fold change; RIX, recombinant inbred intercross; WNV, West Nile virus.
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Genes in cluster 1 (innate immune signaling) include several
molecules involved in RLR signaling, IFN responses, and death
receptor signaling. The coregulated gene module contained ISGs,
Myd88, Oas2, Oas3, Stat2, and Tlr7. Cluster 1 was also enriched for
IFN regulatory factors (Irf3, Irf7, and Irf9). Expression of genes in
this cluster appeared to be activated across all F1s, although not all
met statistical significance. Within the F/F F1s, activation of this
cluster was highly induced only until day 4. This profile is different
from the heterozygous F1s, especially the symptomatic N/F F1 CC
(055x028)F1, which remained induced through day 12. The Oas
genes also appear in cluster 1. These heatmap and qPCR results
display an early termination of innate immune signaling in the
asymptomatic lines that could be influencing disease outcome. Ex-
pression changes in the second cluster (cell signaling) are primarily
influenced by the three heterozygous F1s. The genes in this module
are associated with the cell cycle, DNA replication, DNA repair,
growth, and proliferation. This cluster/gene module showed little
variation across heterozygous F1s and was sparsely suppressed in
the F/F F1s. Expression was inverted at day 12 between the asymp-
tomatic and symptomatic F1s (F/N and N/F, see Table 2), suggesting
that this subcluster links with viral infection and differential WNV
disease.
The expression changes found in CC(055x028)F1 between days
7 and 12 postinfection correspond with viral load. At day 12 post-
infection, we found an increase in viral load in the brain as measured by
qPCR (Figure S6). The gene expression changes between days 7 and 12
postinfection could mark viral spread and subsequent neuroinvasion.
Thecoexpressedgenes found in the thirdcluster (cellmaintenance)are
involved in cell/tissue morphology and leukocyte extravasation (diape-
desis). Genes in this biological pathway are suppressed in expression
relative to mock-infected controls, implying that leukocyte migration is
less active during infection inCC(009x040)F1 (N/N) andCC(055x028)F1
(F/N). Inhibition of leukocytemigration (and supporting chemokines) to
infection sites could destabilize protection against WNV in these F1s.
To validate select innate immune gene expression, we performed
qPCR on two virus-inducible genes: tetratricopeptide repeats 1 (Ifit1)
and IFNb (Ifnb1) using the F1s shown in our heatmap and in Table 2.
Ifit1 and Ifnb1 are IRF3 target genes induced upon WNV infection;
Ifit1 is also an ISG and is highly expressed in response to type 1 or type
3 IFNs. Not surprisingly, Ifit1 induction was highest at day 2 postinfec-
tion, indicative of IRF3 activation and the onset of IFN signaling (Fig-
ure S3 and Figure S4). All F1s appeared elevated for Ifit1 but it was
highest in F/F CC(019x004)F1. Ifit1 decreased by day 4 post-WNV
infection, indicating that viral replication was being controlled. The
Figure 5 Heatmap of QTL genes. Coexpression in spleen at days 2, 4, 7, and 12 postinfection. The heatmap represents differential expression of
21 genes found under the QTL across seven F1s with different Oas1b haplotype (F/F, N/N, F/N, and N/N). Expression is shown as log2(FC) WNV
infected relative to mock. Red marks genes that are upregulated, blue for downregulated, and white represents no log2(FC). The y-axis shows
genes that coregulate based on their directionality and magnitude. The x-axis shows the days postinfection, haplotype, and disease outcome
according to the legend. log2(FC), log2 fold change; QTL, quantitative trait loci; RIX, recombinant inbred intercross; WNV, West Nile virus.
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Ifit1 elevation in N/N F1s at day 2 post-WNV infection indicated in-
duction of IFN production. Ifnb1 appeared low across most of the F1s
in the spleen except the one N/N F1 at day 2 post-WNV infection. This
IFN response was also seen in the brain in the N/N along with virus at
day 7 and suggests that the F/F F1 was protective from the neuro-
invasion (Figure S4). In summary, the gene expression profile of both
F/F and N/N Oas1b haplotypes revealed expressed IFN signaling at
day 2, but this alone did not link with protection in the N/N line.
Transcriptional analysis of genes within the Hrw1 locus
To determine if expression differences in the Oas family members and
other genes within the Hrw1 locus on chromosome 5 (Figure 5) linked
Figure 7 Pathway analysis in the presence (F/F, Functional + Functional Oas1b) and absence (N/N, Non-functional + Non-functional Oas1b) of
functioningOas1b. A bar plot quantifying enrichment of biological pathways across F1s and time points (2, 4, and 7 days) postinfection. The y-axis
indicates time point and biological pathway. The x-axis shows the activation z-score for a pathway. The z-score is based on literature findings and
determines the magnitude of gene regulation for a pathway. Values to the left indicate that pathway is inhibited and values to the right indicate
that pathway is activated. The colors in the bar plot mark the different F1 backgrounds [blue = CC(009x040)F1 and red = CC(006x007)F1].
Figure 6 Oas1b protein. SNPs that impact
aa sequence identified over annotated
(Uniprot) functional domains. Changes in
aa are coded relative to the reference se-
quence, which are identical for the five
classical inbred founder strains, and changes
are assigned to strains (PWK/PhJ = red;
WSB/EiJ = purple; WSB/EiJ and Cast/EiJ =
green; and PWK/PhJ, WSB/EiJ, and CAST/
EiJ = underlined black). aa, amino acid;
DAD (Motif); SNP, single nucleotide poly-
morphism; TM, transmembrane domain.
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with WNV infection outcome, we applied a targeted transcriptional
analysis within the locus. The genes that flank theOas cluster (Dtx1 and
Rph3a) were identified as expressed compared tomock-infection in our
heatmap. There are several genes whose expression was reduced
(downregulated) independently of Oas signatures in the heterozygous
F1s. Interestingly, Rasal1 appeared downregulated in CC(055x028)F1,
which was previously observed with elevated viral load in the spleen
and brain (Scherbik et al. 2006), and this finding was confirmed with
qPCR in the spleen at day 4 postinfection (seeMaterials andMethods).
Rasal1 is an inhibitory regulator of the Ras-cyclic AMP pathway and is
involved in dendrite formation (observed in melanocytes), intercellular
signal transduction, and GTPase activity, and could be implicated in
WNV disease. We also evaluated the expression of other Oas gene
family members and found that the F1s with the largest induction of
Oas genes were CC(017x004)F1 (F/F), CC(019x004)F1 (F/F), and
CC(055x028)F1 (N/N). Oas1b is included in Figure 5 and was in-
duced by WNV infection to be differentially regulated compared to
mock, but was not always statistically different across infection time
points after multiple statistical comparisons.Oasl1 (Oas-like gene 1),
Oas3, and Oas1a were the most highly induced (upregulated) Oas
gene family members across the panel. Oas1a and Oas1g, which are
influential in viral detection and the innate immune response, were
the next highest in expression. Oasl1 has been shown to regulate
IRF7 production (Lee et al. 2013). Oas3 was found upregulated in
each F1 we screened using qPCR and transcriptomics in at least one
time point except for N/N CC(090x040)F1, which had low gene
expression levels. The importance of Oas3 in virus response is cor-
roborated by a previous study that found that OAS3 displayed a
higher affinity for dsRNA than OAS1 or OAS2, which indicated
its contributive role in the antiviral response (Li et al. 2016). Im-
portantly, none of the significant Oas genes were suppressed or
“downregulated” in our analyses. We validated our findings with
qPCR in Oas target genes Oas1g, Oas2, and Oas3. Thus, our analysis
of Oas gene family members is supportive of Oas genes playing a
significant role in antiviral immunity.
Oas1b haplotype distinguishes gene
expression modules
We conducted pathway analysis to assess the biological differences of
significant genes in F1s of differential Oas1b haplotype. As shown in
Figure 6, the Sanger sequencing revealed several polymorphisms within
functional domains of the full-length Oas1b protein among alleles
encoded in the PWK/PhJ, WSB/EiJ, and CAST/EiJ outbred parental
CC strains compared to the C57BL6/J reference strain, while all of the
classical inbred founder strains encoded a stop codon within the
OAS1b C-terminal domain. We first focused on the presence and
absence of full-length Oas1b to reveal differences in gene module ex-
pression between the two groups.
Figure 8 Pathway analysis in the heterozygous Oas1b F1s at day 2 and 4 post-WNV infection. A bar plot similar to day 4 showing enriched
biological pathways. The y-axis indicates the haplotype, time point, and biological pathway. The x-axis shows the activation z-score for a pathway.
Values to the left indicate that pathway is inhibited. Values to the right indicate that pathway is activated. The colors in the bar plot mark the
different F1 backgrounds [blue = CC(003x062)F1 and black = CC(055x028)F1]. CC_ID, Collaborative Cross identifier.
1676 | R. Green et al.
The immune response at day 2 postinfection (Figure 7) was
impacted by Oas1b status. Immune pathways in F/F F1s were pre-
dominantly activated between days 2 and 4 postinfection. Aside
from low level viral recognition, the N/N CC(006x007)F1 did not
show significant activation in immune pathways until day 4 post-
infection. By day 4 postinfection, several pathways were expressed
in parallel, including pathways involving death receptor signaling,
IFN response, toll like receptors, and viral recognition receptors,
thus, marking the onset of the innate immune response. In contrast,
STAT3 signaling was downregulated by day 4 postinfection in the F/F
asymptomatic F1s, reflecting differential STAT3 signaling activity
between the two groups. By day 7 postinfection, the N/N F1 profile
marked a reduced transcriptional response within innate immune
signaling pathways including NF-kb, and pattern recognition recep-
tor signaling, possibly reflecting the progression of WNV infection
out of the spleen onward to the CNS.
To assess gene expression pathways amongOas1b heterozygous F1s,
we concentrated on the day 2 and 4 postinfection time points (Figure
8). These pathway analyses compared the downstream effects of Oas1b
between symptomatic CC(055x028)F1, whose Oas1b allele is derived
fromPWK/PhJ, vs. asymptomatic F/NCC(003x062)F1, whoseOas1b is
from WSB/EiJ. We observed differences in G1/S checkpoint cell cycle
pathways between CC(055x028)F1 and CC(003x062)F1. The pathway
was downregulated in the asymptomatic line, but had very weak in-
duction in the symptomatic line, possibly marking differential pathol-
ogy among the lines. At day 2 postinfection, N/F CC(055x028)F1 had
reduced expression of p53 signaling wherein the other heterozygous
lines showed differential p53 module expression and cell signaling re-
sponse modules at day 4 post-WNV infection. We observed more
extensive gene module regulation in the Oas1b heterozygous mice
overall.
Innate immune regulatory networks
Based on correlation and functional analysis, we proceeded to construct
novel innate immune regulatory networks to discern the unique host
response associated withOas1b allelic differences. Using transcriptional
data from F1s of different Oas1b haplotypes, we identified three im-
mune regulatory networks during WNV infection. Figure 9 represents
the Oas1b allele from both parents (F/F), Figure 10 shows the network
fromOas1b heterozygous (F/N), and Figure 11 shows the network from
Oas1b homozygous nonfunctioning (N/N) mice. The F/F innate (day 2
postinfection) immune network (Figure 9) is comprised of Irf3, Irf7,
Stat1, STAT2, Myc, and the poly(ADP-ribose) polymerase family of
proteins (PARP) response networks, and includes the Oas gene cluster.
Irfs and Stats were the major hubs launching virus-responsive genes
and ISG networks, alongwith the induction of theOas pathway. IRF3/7
also connects with several pattern recognition receptors including
DDX58 (the RLRs), IFIH1, and DDX60. PARP genes contribute to
Figure 9 Innate immune regulation network [Oas1b allele (F/F)]. Innate immune regulatory network identified in F1s with F/F Oas1b alleles. Each
node represents a gene with different colored lines showing types of connectivity. Filled-in nodes are target genes from the dataset.
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death receptor signaling and apoptosis while Mx1/Mx2 are ISGs in-
volved in antiviral innate immunity against several viruses (Shaffer
et al. 2001). Antigen presentation is clearly activated, as indicated
through network connections among the MHC class I family of genes.
ABCF3 is connected by MYC (myelocytomatosis) and performs vari-
ous roles in the cell, and has been identified as an Oas1b-binding pro-
tein of WNV control (Courtney et al. 2012). IFIT1B and SNRPD3
(small nuclear ribonucleoprotein) connect to ORP1L, another Oas1b-
binding protein. Thus, network analysis of F/F Oas1b mice reveals
innate immune and antigen processing induction, OAS protein expres-
sion, and network interaction of known Oas1b-binding proteins in
response to WNV associated with homozygous full-length Oas1b
genotype.
The innate (day 2 postinfection) heterozygous network (F/N) in
Figure 10 shared genetic signatures with F/F and included STAT3 as
one of the network hubs. Additional hubs included EED (embryonic
ectoderm development),MYC, and POU5F1 (POU class 5 homeo box
1), major cell signaling pathways (Neri et al. 2012; Shaw and Martin
2009). Along with STAT3, the heterozygous network also connects the
OAS pathway genes (1–3 including Oas1b). Unique to this network is
the incorporation of DAXX (death domain associated protein) and
Mov10 (RISC complex RNA helicase). DAXX is involved in death re-
ceptor signaling and targets infected cells for apoptosis (Engelhardt
et al. 2001; Li et al. 2000; Perlman et al. 2001).Mov10 is an IFN-inducible
gene recently shown to have antiviral activity against RNA viruses like
Sendai and VSV, but not seen before in WNV. This network again
supports previous work (Courtney et al. 2012) where ABC proteins
are binding partners toOas1b, as noted above. In our network, we also
identified connections with ABCF1 and ABCF2.
The N/N network, derived from later time points (days 7 and
12 postinfection), are involved in cell-to-cell signaling interactions
and RNA post-translational modifications. There are several connector
hubs in this network driven by genesPLCG1, GRB2, andFYN.PLCG1 is
involved in CD28 signaling in T helper cells and apoptosis. GRB2 is a
growth factor receptor signaling-adaptor protein and is involved in a
variety of cell signaling programs (Jang et al. 2009). Interestingly,
ABCF3 is connected to GRPB2 through protein interactions with
HIRIP3 (HIRA-interacting protein 3) and CSNK2A2 (casein kinase
2 a 2). It is believed that HIRIP3 functions as part of a multi-protein
complex with roles in chromatin and histone metabolism. CSNK2A2 is
a kinase, and has roles in apoptosis and G2/M phase cell cycling.
ORP1L is connected to GRB2 through interactions with growth factor
KITLG (Kit ligand). KITLG has several cellular roles including differ-
entiation and apoptosis. The N/N network shares a STAT3 hub with
the F/N network but its interaction partner is the FYN proto-oncogene
(Src family tyrosine kinase family), which is involved in ATP binding as
well as CD4 and CD8 receptor binding. Toll-like receptor 4 (TLR4), a
well-documented immune signaling receptor, is downregulated. Taken
together, these results link Oas1b haplotype with differential gene net-
works and WNV infection outcome.
Identifying regulatory factors in host innate
immune signaling
Our results show that F1s containing functionalOas1b alleles from both
parents do not succumb to WNV infection. To determine the regula-
tors of transcriptional responses in these Oas1b F/F F1s, we performed
a predicted regulator analysis to localize target genes and find addi-
tional transcriptional regulators necessary for protection. Our regulator
Figure 10 Innate immune regulation network [Oas1b allele (F/N)]. Innate immune regulatory network identified in F1s with F/N Oas1b alleles.
Each node represents a gene with different colored lines showing types of connectivity. Filled-in nodes are target genes from the dataset.
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network (Figure 12) revealed that gene expression upregulation oc-
curred predominantly in ISGs at day 2 postinfection. The network
analysis determined activation of four transcriptional regulators
(IRF3, IRF5, IRF7, and NCOA2). Three of these—IRF3, IRF5, and
NCOA2—have been functionally linked to innate immune regulation
orWNV infection in previous studies (Lazear et al. 2013; Flammer et al.
2010). The regulators and their candidate genes shared two distinct
operations: antiviral response and inhibition of viral replication.
Among the target genes in the networkwereOasmembers,Mx1, and
various chemokines. Additionally, BAK1 (BCL antagonist/killer 1) and
ZBP1 (Z-DNA binding protein 1) are present in the network and play
roles in cell cycle regulation and proapoptotic activity; each are putative
IRF-target genes. FCGR1A FC g receptor is also linked to this network
and is known to function in antigen presentation and removal of in-
fected cells via apoptosis. NCOA2 is an Oas1b F/F network gene and is
a transcriptional coregulatory protein with multiple nuclear interacting
domains allowing DNA to become more accessible for transcription.
Oas1 and 2 expression is in part mediated by IRFs and NCOA2; studies
using mouse bone-derived macrophages lacking NCOA2 expression
showed a decrease in ISG expression (Flammer et al. 2010). Thus,
WNV infection in the context of the F/F Oas1b haplotype engages
specific IRF, IFN, and virus-responsive transcriptional networks that
mediate protection from neuroinvasion and disease.
DISCUSSION
Infectious diseases cause a wide range of responses across genetically
diverse populations. The use of genetically diverse MPP within the
infectious disease community has been increasing with an effort to
characterize (Iraqi et al. 2012; Ferris et al. 2013; Rasmussen et al. 2014;
Graham et al. 2015, 2016) and genetically define the range of disease
responses under host genetic control during viral infections (Boon et al.
2009; Ferris et al. 2013; Gralinski et al. 2015, 2017). Here, we confirmed
a role for variants at theOas1b locus in driving major disease outcomes
following WNV infection. By leveraging prior gene sequence informa-
tion of the Oas1b gene, we subclassified our F1s into four diplotype
classes at the Oas1b locus. We found significant within-class variation
in disease outcomes in these F1s, utilized transcriptional analysis to
identify key host genes (and pathways) involved in allelic differences,
and obtained a comprehensive view of the innate immune response
associated with Oas1b haplotype variation.
Figure 11 Innate immune regulation network [Oas1b allele (N/N)]. Innate immune regulatory network identified in F1s with N/N Oas1b alleles.
Each node represents a gene with different colored lines showing types of connectivity. Filled-in nodes are target genes from the dataset.
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Genetic variation impacts disease
The Oas1b gene has been shown (Bigham et al. 2011; Courtney et al.
2012) to play a major role in controllingWNV disease by limiting viral
replication (Kajaste-Rudnitski et al. 2006) within the C3Hmouse strain
(Perelygin et al. 2002).We identified amajor-effectQTL over theOas1b
locus within a large population of F1s, and this QTL showed allele
effects consistent with the previously described sequence variation
within Oas1b. Importantly, this variant appears to segregate between
wild-derived inbred strains and classical inbred strains derived from
small population fancy mice (Yang et al. 2011). While our study and
previous ones cannot definitively answer the question of whether the
mutation arose in natural populations or in laboratory mice, it high-
lights the utility of assessing a broader range of genetic variants (both at
targeted loci and genome-wide) in dissecting disease responses.
The presence of genes of major effect within genetic reference or
other mapping populations can overshadow effects of other genetic
variants cocirculatingwithin these populations.As seen inour studyand
others (Ferris et al. 2013), it is possible to detect, transcriptionally
characterize, and genetically map variants modifying disease responses
in the presence of a major gene. As many pathogens and other diseases
are impacted by large-effect genes (Ferris and Heise 2014), care in the
design of experiments and their resultant analysis within the context of
reference populations must be given. As we have shown here, studies
further characterizing between-class responses at a molecular level can
improve insight into disease mechanisms. Alternatively, studies such as
F2 crosses or molecular investigations of strains within an allele class
can identify specific variants modifying disease and will help to expand
our knowledge of naturally polymorphic networks driving aberrant
disease responses.
Oas1b has been shown to act independently from the RNase L
pathway to mediate protection against WNV infection. OAS1b lacks
OAS activity, and hence does not produce 2-5A that otherwise binds
and activates RNaseL (Brinton and Perelygin 2003; Perelygin et al.
2002). In addition to ABC and ORP1L protein binding by OAS1b,
our network analysis also observed additional factors implicated in
Oas haplotype control of WNV infection including DAXX (mediated
apoptosis), Mov10 (antiviral), GRB2 (cell signaling and leukocyte mi-
gration), and Trafd1. Trafd1 has not previously been associated with
theOas family but appears within our QTL heatmap (Figure 5). Trafd1
is an immune regulator known to be activated by STAT1 in mouse
bone-derived macrophages (Mashima et al. 2005), and possibly con-
tributes to innate immune protection mediated by this Oas1b network.
Evolutionary studies have observed that there is a balancing selection
occurring at the Oas1 gene locus across the human and nonhuman
primate species. The allelic drift between primates produced variations
in amino acids associated with RNA binding and this contributed to
the susceptibility to flaviviruses (Ferguson et al. 2008). By performing
a large genome scan across our diverse mouse backgrounds, we
Figure 12 Infection regulator network F/F. A regulatory network generated from differentially expressed genes in CC(019x004)F1 at day
2 postinfection. The top nodes are transcriptional regulators. The red regulator was observed in the expression data and the orange nodes are
predicted based on the target genes in our data set. The row of red-colored nodes indicate target genes that are upregulated. The lower orange
and blue nodes refer to functional Gene Ontology (GO) terms. Antiviral response (GO:0050691) is predicted to be activated and replication of
virus (GO:0019079) is predicted to be inhibited.
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confirmed aQTL (containing theOas genes and others) correlated with
WNV infection. We chose here to observe the transcriptional differ-
ences influenced byOas1b using the CC and allelic effects to determine
the differential outcome (Figure S1). Our transcriptional analysis
showed that there is still considerable strain-specific variation within
the F1 backgrounds with functionalOas1b. While true disentangling of
the relationship between genetic variants within these transcriptional
networks andOas1b allelic variants (e.g., via genome editingOas1b loci
within CC strains) is beyond the scope of this study, our results
strongly suggest that the anti-WNV effect of Oas1b leads to differ-
ential activation of molecular programs. Further work to under-
stand these programs, the role of genetic variants within its
members, and the causal role of Oas1b, will help to elucidate the
mechanisms of WNV disease and point to potential therapeutic
responses to this disease.
Weobserved for thefirst time the roleofparental effectsofOas1b and
their differential host transcriptomics. Among the heterozygous F1s, we
noted a slightly higher survival rate in F1s where Oas1b was functional
in the mother (F/N). We also observed three immune regulatory net-
works influenced by WNV infection and the Oas1b haplotype. Our
analysis found a surprising relationship with cell cycle checkpoint sig-
naling, diapedesis, and Oas1b haplotype. We found that the Mov10
gene was included in this network of gene activation in F1s with het-
erozygous F/N alleles. Interestingly,Mov10 has been shown previously
to function in an IRF3-dependent manner independent of the RIG-I
pathway (Cuevas et al. 2016), implicating possible RIG-I-independent
signaling within theOas1b network to drive gene expression within this
module.
We were also able to assemble an innate immune network linking
functional Oas1b to proteins including IRFs, specific ISGs, ubiquitin
protein ligases, and PARP genes. The F/F and some F/N F1s displayed
earlier viral recognition, which appeared in transcriptional pathway
analysis and qPCR through Ifit1 and Ifnb1 expression. In symptomatic
F1s lacking functional Oas1b (N/N), transcriptomics profiling indi-
cated a lack of innate immune induction and cell migration that in-
cluded monocyte migration and macrophage development. These
observations indicate that, without activation of key processes such as
innate immune signaling, diapedesis, and IFN responses, the host is
unable to develop a strong defense and thus succumbs to infection in a
manner linked to loss ofOas1b function. For example, the symptomatic
N/F CC(055x028)F1 was unable to control viral replication in the
spleen and developed neuroinvasive infection by day 12 (Figure S4).
Lastly, our regulatory network (Figure 12) identified nuclear receptor
coactivator 2 (NCOA2) as a novel transcriptional regulator producing
an antiviral effect linked with Oas1b.
Understanding why some people are susceptible to viral infection
whileothers are resistant is bothagenetics andagenomics challenge that
can be studied through genetics reference populations and infection
models like the CC. Our study identifies new features of gene regulation
linked with differential Oas1b genotypes within varied genetic back-
grounds. This work also affirms the CC as a valuable tool for revealing
the genetics of immune regulation and WNV control. CC mouse pop-
ulation is therefore an optimal model of virus infection amenable to
defining genetic traits of disease outcome.
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